|
gptkbp:instanceOf
|
gptkb:cancer
gptkb:disease
|
|
gptkbp:affects
|
children
|
|
gptkbp:associatedWith
|
gptkb:ALK
gptkb:PHOX2B
|
|
gptkbp:canMetastasizeTo
|
gptkb:bone
gptkb:skin
liver
lymph nodes
|
|
gptkbp:canRegressSpontaneously
|
yes
|
|
gptkbp:cause
|
gptkb:opsoclonus-myoclonus_syndrome
gptkb:paraneoplastic_syndromes
|
|
gptkbp:clinicalTrialPhase
|
gptkb:Children's_Oncology_Group
|
|
gptkbp:color
|
gold ribbon
|
|
gptkbp:commonAgeOfDiagnosis
|
under 5 years
|
|
gptkbp:diagnosedBy
|
imaging
biopsy
urine catecholamines
|
|
gptkbp:firstDescribed
|
1864
|
|
gptkbp:hasAwarenessMonth
|
September
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Neuroblastoma
|
|
gptkbp:ICD-10_code
|
C74.9
|
|
gptkbp:incidence
|
about 1 in 7,000 live births
|
|
gptkbp:marking
|
elevated homovanillic acid
elevated vanillylmandelic acid
|
|
gptkbp:mayPresentWith
|
gptkb:Horner's_syndrome
hypertension
proptosis
|
|
gptkbp:mortalityRate
|
high in advanced stages
|
|
gptkbp:mostCommonSolidTumorIn
|
infants
|
|
gptkbp:originatedIn
|
gptkb:neural_crest_cells
|
|
gptkbp:prognosis
|
gptkb:theatre
age at diagnosis
MYCN amplification
|
|
gptkbp:riskFactor
|
family history
genetic mutations
|
|
gptkbp:stagingSystem
|
gptkb:INSS
INRG
|
|
gptkbp:symptom
|
fever
weight loss
bone pain
abdominal mass
|
|
gptkbp:treatment
|
surgery
radiation therapy
chemotherapy
immunotherapy
stem cell transplant
|
|
gptkbp:website
|
adrenal glands
sympathetic nervous system
|
|
gptkbp:bfsParent
|
gptkb:Threonine_58
|
|
gptkbp:bfsLayer
|
7
|